Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer

Detalles Bibliográficos
Autores principales: Rajan, Narayan, Barraclough, Helen, Puri, Tarun, Orlando, Mauro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434144/
https://www.ncbi.nlm.nih.gov/pubmed/26076001
http://dx.doi.org/10.1016/j.gore.2014.09.002
_version_ 1782371734076260352
author Rajan, Narayan
Barraclough, Helen
Puri, Tarun
Orlando, Mauro
author_facet Rajan, Narayan
Barraclough, Helen
Puri, Tarun
Orlando, Mauro
author_sort Rajan, Narayan
collection PubMed
description
format Online
Article
Text
id pubmed-4434144
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-44341442015-06-05 Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer Rajan, Narayan Barraclough, Helen Puri, Tarun Orlando, Mauro Gynecol Oncol Rep Letter to the Editor Elsevier 2014-10-12 /pmc/articles/PMC4434144/ /pubmed/26076001 http://dx.doi.org/10.1016/j.gore.2014.09.002 Text en © 2014 The Authors http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Letter to the Editor
Rajan, Narayan
Barraclough, Helen
Puri, Tarun
Orlando, Mauro
Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
title Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
title_full Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
title_fullStr Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
title_full_unstemmed Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
title_short Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
title_sort cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages iib–iva cervical cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434144/
https://www.ncbi.nlm.nih.gov/pubmed/26076001
http://dx.doi.org/10.1016/j.gore.2014.09.002
work_keys_str_mv AT rajannarayan costeffectivenessofconcurrentgemcitabineandcisplatinandradiationfollowedbyadjuvantgemcitabineandcisplatininstagesiibivacervicalcancer
AT barracloughhelen costeffectivenessofconcurrentgemcitabineandcisplatinandradiationfollowedbyadjuvantgemcitabineandcisplatininstagesiibivacervicalcancer
AT puritarun costeffectivenessofconcurrentgemcitabineandcisplatinandradiationfollowedbyadjuvantgemcitabineandcisplatininstagesiibivacervicalcancer
AT orlandomauro costeffectivenessofconcurrentgemcitabineandcisplatinandradiationfollowedbyadjuvantgemcitabineandcisplatininstagesiibivacervicalcancer

Ejemplares similares